With the end of its crowdfunding operation, Enovap has decided to take stock and offer it to us through an official press release. This innovative project was a hit, exceeding its initial target by 114%. If you also want to get your "Enovap" don't forget to try your luck in our contest which ends tonight!
Crowdfunding and e-health: ENOVAP goes far beyond its objectives !
At the end of its first crowdfunding campaign, ENOVAP, the 1st smart nicotine withdrawal support device (combining a connected e-cigarette and mobile application), exceeds swe have an initial goal of 114%.
ENOVAP, a success story
«Beyond the total amount collected, the real success is to have known how to meet our public »Explains Alexandre Scheck, CEO of Enovap. In fact, from the first 24 hours of the campaign, 2/3 of the way to go had already been reached.
Finally, this campaign is a real success, with 64 302 euros collected, an objective exceeded by 114%. " In addition, this campaign has also raised awareness among many potential distributors, stores specialized in the electronic cigarette obviously, but also pharmacists sensitive to our concept“, Adds Alexandre Scheck.
To thank the contributors (206) for their support, 5 new colors of leather covers have been released, in addition to the first 7 color choices! Pre-orders linked to the campaign will be delivered in December 2016, when ENOVAP will be present in all distribution channels.
ENOVAP: Crowdfunding at a future fundraiser
« We are proud to have allowed ENOVAP to carry this campaign. They managed to unite their community, which is the keystone of a successful crowdfunding campaign. »Explains Fabrice Nabet, co-founder and CEO of Wellfundr, the crowdfunding platform specializing in healthcare which carried the ENOVAP campaign.
This crowdfunding campaign was a real demonstrator of the relevance of the concept of ENOVAP for the founders of the startup. " We are in the process of raising funds to enable us to consolidate our industrial development, but also to program our commercial development and our R&D Says Alexander Scheck. " This campaign seemed to us necessary to demonstrate that not only our concept is of great interest to health professionals, especially tobacco doctors and addictologists, but that the general public is also ready to join"
Through this successful campaign, the future of ENOVAP is emerging: a first fundraising to finalize the production and marketing processes and, above all, the start of a study allowing to consider in the medium term medical device status for the ENOVAP connected cigarette and its companion application.
The " Hit Control Is the 1st intelligent system for managing nicotine concentration via an intelligent connected electronic cigarette. This new concept aims to better support smokers towards smoking cessation. To move from concept to reality, and allow healthcare professionals to benefit from ENOVAP's contributions in the care of smokers, it is therefore essential for ENOVAP to move towards the status of medical device in order to be a real health product. " This is what we are heading towards, in particular, by setting up the first large-scale French study linked to smoking cessation via electronic cigarettes.“, Announces Alexandre Scheck.
To learn more about Enovap visit their official website. An Enovap is up for grabs with Vapoteurs.net by taking part in our big contest on Facebook (click here to participate).
